SERPINA3 and asthma: In one such study in which findings from the next gen proteomics approach was validated by enzyme-linked immunosorbent assay (ELISA), SERPINA3 was found to be higher in patients with asthma and was particularly higher in patients with an acute exacerbation of their asthma [34].